China puts on display its first COVID-19 vaccine candidates

Makers expect these vaccines to hit the market by year-end following required approvals after the phase-3 trials

Vaccine
An intranasal vaccine will not only be simple to administer but reduce the use of medical consumables such as needles, syringes, etc., significantly impacting the overall cost of a vaccination drive, Bharat Biotech CMD said. Representational image: iStock

China, where the coronavirus outbreak was reported first, for the first time put on display its homegrown vaccine for the infection at a Beijing trade fair this week.

A crowd gathered around small vials of liquid – vaccine candidates by Chinese firms Sinovac Biotech and Sinopharm – at the trade fair on Monday (September 7), reported AFP.

The makers of the vaccines expect these to hit the market by year-end following required approvals after the phase-3 trials.

A vaccine factory capable of producing 300 million doses a year has been constructed, the report quoted a Sinovac representative as saying.

Global Times of China had last month reported that the price of the vaccines will not be high. Quoting Sinopharm’s chairman it had said two doses of the vaccine should cost less than 1,000 yuan ($146), AFP reported.

China had been under fire from several countries for alleged mishandling of the pandemic in its initial days with US President Donald Trump going to the extent of calling the infection “Chinese virus”.

Related news: China using COVID vaccine which is yet to clear Stage-3 trials: Report

Get breaking news and latest updates from India
and around the world on thefederal.com
FOLLOW US: